Skip to main content
Top
Published in: Infection 4/2016

01-08-2016 | Case Report

The rationale for third trimester testing of vertical HIV transmission in neonates with CMV infection

Authors: Vinzenz Boos, Cornelia Feiterna-Sperling, Akosua Sarpong, Lars Garten, Malte Cremer, Katharina von Weizsäcker, Christoph Bührer, Christof Dame

Published in: Infection | Issue 4/2016

Login to get access

Abstract

We report on a late-preterm neonate with severe congenital cytomegalovirus (CMV) infection, refractory to antiviral therapy with ganciclovir. Subsequent immune diagnostics led to the finding of HIV infection at day 69, even though the mother tested negative for HIV in early pregnancy. Thus, in congenital CMV infection, HIV testing should be performed to elucidate maternal HIV seroconversion during late pregnancy. Our case strongly supports third trimester screening of HIV infection acquired during pregnancy, yet recommended only for women with traditional risk factors for HIV or living in an area of high HIV prevalence.
Literature
1.
go back to reference Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253–76.CrossRefPubMed Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253–76.CrossRefPubMed
2.
go back to reference Oliver SE, Cloud GA, Sánchez PJ, et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009;46:22–6.CrossRef Oliver SE, Cloud GA, Sánchez PJ, et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009;46:22–6.CrossRef
3.
go back to reference Kimberlin DW, Acosta EP, Sánchez PJ, et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008;197:836–45.CrossRefPubMed Kimberlin DW, Acosta EP, Sánchez PJ, et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008;197:836–45.CrossRefPubMed
4.
go back to reference Cremer M, Weimann A, Schmalisch G, et al. Immature platelet values indicate impaired megakaryopoietic activity in neonatal early-onset thrombocytopenia. Thromb Haemost. 2010;103:1016–21.CrossRefPubMed Cremer M, Weimann A, Schmalisch G, et al. Immature platelet values indicate impaired megakaryopoietic activity in neonatal early-onset thrombocytopenia. Thromb Haemost. 2010;103:1016–21.CrossRefPubMed
5.
go back to reference Roux W, Pieper C, Connon M. Thrombocytopenia as marker for HIV exposure in the neonate. J Trop Pediatr. 2001;47:208–10.CrossRefPubMed Roux W, Pieper C, Connon M. Thrombocytopenia as marker for HIV exposure in the neonate. J Trop Pediatr. 2001;47:208–10.CrossRefPubMed
6.
go back to reference Duryea EL, Sánchez PJ, Sheffield JS, et al. Maternal human immunodeficiency virus infection and congenital transmission of cytomegalovirus. Pediatr Infect Dis J. 2010;29:915–8.CrossRefPubMed Duryea EL, Sánchez PJ, Sheffield JS, et al. Maternal human immunodeficiency virus infection and congenital transmission of cytomegalovirus. Pediatr Infect Dis J. 2010;29:915–8.CrossRefPubMed
7.
go back to reference Mwaanza N, Chilukutu L, Tembo J, et al. High rates of congenital cytomegalovirus infection linked with maternal HIV infection among neonatal admissions at a large referral center in sub-Saharan Africa. Clin Infect Dis. 2014;58:728–35.CrossRefPubMed Mwaanza N, Chilukutu L, Tembo J, et al. High rates of congenital cytomegalovirus infection linked with maternal HIV infection among neonatal admissions at a large referral center in sub-Saharan Africa. Clin Infect Dis. 2014;58:728–35.CrossRefPubMed
8.
go back to reference Frederick T, Homans J, Spencer L, et al. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants. Clin Infect Dis. 2012;55:877–84.CrossRefPubMed Frederick T, Homans J, Spencer L, et al. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants. Clin Infect Dis. 2012;55:877–84.CrossRefPubMed
9.
go back to reference Moses SE, Tosswill J, Sudhanva M, et al. HIV-1 seroconversion during pregnancy resulting in vertical transmission. J Clin Virol. 2008;41:152–3.CrossRefPubMed Moses SE, Tosswill J, Sudhanva M, et al. HIV-1 seroconversion during pregnancy resulting in vertical transmission. J Clin Virol. 2008;41:152–3.CrossRefPubMed
10.
go back to reference Roongpisuthipong A, Siriwasin W, Simonds RJ, et al. HIV seroconversion during pregnancy and risk for mother-to-infant transmission. J Acquir Immune Defic Syndr. 2001;26:348–51.CrossRefPubMed Roongpisuthipong A, Siriwasin W, Simonds RJ, et al. HIV seroconversion during pregnancy and risk for mother-to-infant transmission. J Acquir Immune Defic Syndr. 2001;26:348–51.CrossRefPubMed
11.
go back to reference Johnson LF, Stinson K, Newell ML, et al. The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2012;59:417–25.CrossRefPubMedPubMedCentral Johnson LF, Stinson K, Newell ML, et al. The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2012;59:417–25.CrossRefPubMedPubMedCentral
12.
go back to reference De Schacht C, Hoffmann HJ, Mabunda N, et al. High rates of HIV seroconversion in pregnant women and low reported levels of HIV testing among male partners in Southern Mozambique: results from a mixed methods study. PLoS One. 2014;9:e115014.CrossRefPubMedPubMedCentral De Schacht C, Hoffmann HJ, Mabunda N, et al. High rates of HIV seroconversion in pregnant women and low reported levels of HIV testing among male partners in Southern Mozambique: results from a mixed methods study. PLoS One. 2014;9:e115014.CrossRefPubMedPubMedCentral
13.
go back to reference Faghih S, Secord E. Increased adolescent HIV infection during pregnancy leads to increase in perinatal transmission at urban referral center. J Int Assoc Physicians AIDS Care (Chic). 2012;11:293–5.CrossRef Faghih S, Secord E. Increased adolescent HIV infection during pregnancy leads to increase in perinatal transmission at urban referral center. J Int Assoc Physicians AIDS Care (Chic). 2012;11:293–5.CrossRef
15.
go back to reference Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR14):1–17.PubMed Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR14):1–17.PubMed
16.
go back to reference Committee on Obstetric Practice and HIV Expert Work Group. Committee opinion no: 635: prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstet Gynecol. 2015;125:1544–7. Committee on Obstetric Practice and HIV Expert Work Group. Committee opinion no: 635: prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstet Gynecol. 2015;125:1544–7.
Metadata
Title
The rationale for third trimester testing of vertical HIV transmission in neonates with CMV infection
Authors
Vinzenz Boos
Cornelia Feiterna-Sperling
Akosua Sarpong
Lars Garten
Malte Cremer
Katharina von Weizsäcker
Christoph Bührer
Christof Dame
Publication date
01-08-2016
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 4/2016
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0876-0

Other articles of this Issue 4/2016

Infection 4/2016 Go to the issue